Wildbull — Market Intelligence Workbench

MRNAModerna, Inc.+14.2%

Doubler score 76 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades

10-09O 199.00H 225.00L 197.17C 225.00+14.21%MA20MA50

F10-28 · FOMC rate decision (in 19 days)
A10-09 · Moderna, Inc. Stock 12‑Month Price Targ…
709-01 · vs. S&P +10.6%
809-21 · vs. S&P +10.7%
910-06 · vs. S&P -8.3%
1010-09 · vs. S&P +13.6%

LITELumentum+5.2%

Doubler score 73 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades

HUMHumana+11.6%

Doubler score 62 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades

IOVAIovance Biotherapeutics+9.8%

Doubler score 77 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased

PLTRPalantir Technologies+5.2%

Doubler score 77 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades

SNOWSnowflake+7.4%

Doubler score 77 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades

DDOGDatadog+7.1%

Doubler score 69 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades

CAICaris Life Sciences+8.0%

Doubler score 76 · Positive 3- and 6-month returns · Above the 200-day average · More estimate upgrades than downgrades

Of 0 stocks today, 0 are worth a closer look.